Loading...

Digital Healthcare And Precision Diagnostics Will Shape Tomorrow

Published
29 Aug 25
Updated
13 Sep 25
AnalystConsensusTarget's Fair Value
JP¥1,045.00
7.0% undervalued intrinsic discount
13 Sep
JP¥972.00
Loading
1Y
-6.1%
7D
2.1%

Author's Valuation

JP¥1.05k7.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on13 Sep 25
Fair value Increased 6.81%

Despite a slight decline in consensus revenue growth expectations, an improved net profit margin has driven a higher consensus analyst price target for PHC Holdings, which has increased from ¥978 to ¥1045. What's in the News Board approved signing a memorandum of understanding to transfer the commercial operation of Eversense Continuous Glucose Monitoring System from subsidiary Ascensia Diabetes CareHoldings AG to Senseonics Holdings, Inc.